AROA BIOSURGERY LIMITED ARBN 638 867 473 NZCN 1980577 64 Richard Pearse Drive, Auckland 2022, New Zealand AROA.COM ASX ANNOUNCEMENT 7 October 2026 I N V I T E T O I N V E S T O R W E B I N A R O N S Y M P H O N Y R C T Aroa Biosurgery Limited (ASX: ARX, ‘AROA’ or the ‘Company’) will host...
Invite to Investor Webinar on Symphony RCT
Filed with ASX · · 1 page · English
Release
In the deck
Story so far
Earlier from Aroa Biosurgery
- Investor Presentation - MASTRR Interim Analysis
- Change in substantial holding
- Symphony™ Randomized Controlled Trial Demonstrates Significantly Improved Healing of Diabetic Foot Ulcers
- Symphony Significantly Improves DFU Healing
- Invite to Investor Webinar on MASTRR Interim Analysis
Later from Aroa Biosurgery
- Investor Presentation - Symphony RCT
- Notification of cessation of securities - ARX
- Molnlycke to Co-promote Endoform In the US
- Change in substantial shareholding for ARX
- AROA Appoints Mark Dunwoodie as CFO
Follow Aroa Biosurgery into a list and get an email when it puts out news.
Follow Aroa Biosurgery